Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases
Franziska M. Ippen(Harvard University), Priscilla K. Brastianos(Massachusetts General Hospital)
Cited by 99
Related Papers
Longitudinal molecular trajectories of diffuse glioma in adults
|Nature|2019|594
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
|Neuro-Oncology|2020|258
Evolution of delayed resistance to immunotherapy in a melanoma responder
|Nature Medicine|2021|135
Landscape of Genomic Alterations in Pituitary Adenomas
|Clinical Cancer Research|2016|133